Hershey to launch protein powder to target GLP-1 users

Hershey is planning to release a new protein powder in January as part of a strategy to reach health-conscious consumers and those using GLP-1 weight-loss medications. The company is looking to innovate as appetite-suppressing drugs impact traditional snacking habits.

CEO Kirk Tanner has increased research and development spending by 25% to drive product innovation. In addition to the protein powder project, which is a partnership with VitaKey, Hershey is expanding its gum and mints division to address side effects associated with weight-loss drugs, such as bad breath. The company is also exploring savory offerings and portion-controlled packaging to adapt to changing consumer behaviors.